Feb 16, 2010 2:01am EST Rigel to Host Conference Call Today to Discuss Its Partnership With AstraZeneca on Fostamatinib Disodium (R788)
Feb 16, 2010 2:00am EST AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
Dec 23, 2009 7:30am EST Rigel Receives Milestone Payment from Daiichi Sankyo for Cancer Ligase Target
Sep 17, 2009 9:19am EDT Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
